Large-scale testing (Phase 3)Study completedNCT03782376
What this trial is testing
Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease
Who this might be right for
Crohn Disease
Janssen-Cilag Ltd. 215